Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-25

Clinical Trial Update: The Use of Platelet Derived Growth Factors in Total Knee Arthroplasty, a Randomized Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating the use of platelet-derived growth factors in total knee arthroplasty for osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-derived growth factors (platelet growth factors)

Snippet

Sponsor: Westfries Hospital | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED